Learning Objectives

Upon completion of this course, participants will be able to:

  1. Describe the rationale for using HCT as a treatment for hematologic dyscrasias and immune disorders, the HCT procedure, and the typical short- and long-term effects. Identify general HCT patient/survivor and caregiver outcomes, both medical and psychosocial.
  2. Describe the types of hematological dyscrasias most frequently treated with autologous transplant and the unique stressors and sequelae that come with this treatment.
  3. Describe the types of hematological dyscrasias most frequently treated with allogeneic transplant and the unique stressors and sequelae that come with this treatment, and identify the incidence of GVHD.
  4. Be able to identify at least 2 differences between the psychosocial sequelae of autologous and allogeneic transplant.
  5. Demonstrate a basic understanding of GVHD, differentiate acute vs chronic, GVHD, describe the unique medical and psychosocial challenges that GHVD patients and caregivers experience, and discuss psychotherapeutic treatment modalities to address those challenges.
  6. Describe the types of hematological dyscrasias most frequently treated with CAR T-cell therapy and the unique stressors and medical and psychosocial sequelae that come with this treatment.
  7. Describe the incidence of and risk factors associated with common psychiatric disorders which occur during each phase of the HCT process, as well as identify the psychiatric sequelae of common medications used to treat hematologic malignancies, HCT complications, and GVHD.

Course Summary

Hematopoietic stem cell transplantation (HCT) and CAR T-cell therapy are two intensive therapies used to treated patients with advanced hematologic malignancies and certain genetic/immune system disorders. The intensity of the treatment, as compared to standard chemotherapy used to treat cancer patients, generates a unique set of medical and psychosocial consequences that are critical for mental health professionals (MHP) to understand in order to most effectively support and treat these patients.

This course will provide:

  1. A broad overview of HCT including rationale for its use, eligible patients, short-term, long-term and late effects, and impact on patients’ and caregivers’ overall quality of life (QOL) and health behaviors (Module 1: Drs. Wingard)
  2. An in-depth overview of the psychosocial issues experienced by all stem cell transplant patients and family caregivers prior to, during, and after transplant, as well as into long term survivorship (Module 2: Dr. Bishop)
  3. An in-depth review of the medical consequences of undergoing an autologous HCT. (Autologous stem cell transplants are a treatment option for patients with multiple myeloma, non-Hodgkin lymphoma, Hodgkin Disease and some solid tumors.) (Module 3: Dr. Bociek)
  4. An in-depth review of the medical consequences of undergoing an allogeneic HCT (a transplant using donor cells) before, during and after treatment. (Allogeneic stem cell transplants are a treatment option for patients with leukemia, myelodysplastic syndromes, myeloproliferative disorders as well as some genetic inherited disorders such as sickle cell disease.) (Module 4: Dr. Battiwala)
  5. An in-depth review of the psychosocial issues that autologous and allogeneic stem cell transplant recipients experience, with an emphasis on the issues that are similar and those that are different between the two types of stem cell transplant (Module 5: Dr. Muenks)
  6. An in-depth review of the medical consequences of graft-versus-host disease (GVHD) the major complication of an allogeneic HCT. (Module 6: Dr. Alousi)
  7. An in-depth review of the psychosocial consequences of living with graft-versus-host disease (GVHD) the major complication of an allogeneic HCT. (Module 7: Dr. Bishop)
  8. A discussion of the most common psychiatric issues that occur in the HCT setting and their management (Module 8: Dr. Rueda-Lara)
  9. An in-depth review of the medical and psychosocial consequences of a new cellular therapy called CAR T-cell therapy. (CAR T-cell therapy is a treatment option for patients with advance-stage cases of acute medical and psychosocial consequences lymphoblastic leukemia (ALL), multiple myeloma and some form of non-Hodgkin lymphoma.) (Module 9: Dr. El-Jawahri)

At the conclusion of this course, MHPs will have a better understanding of why and when HCT and CAR T-cell therapy is offered to patients; potential short-term and long-term consequence of each treatment, as well as late effects; psychosocial issues common and unique among patients undergoing HCT or CAR T-cell therapy; and psychological and psychiatric treatment modalities that have proven beneficial for this patient population.

Course Curriculum

Created & Published: June 2023

    1. 1a - The Nuts and Bolts of Hematopoietic Cell Transplantation (HCT) - Medical Issues - Dr. John Wingard

    2. 1b - The Nuts and Bolts of Hematopoietic Cell Transplantation (HCT) - Psychosocial Issues - Dr. Michelle Bishop

    3. 1c - The Nuts and Bolts of Hematopoietic Cell Transplantation (HCT) - The Patient Experience - Mr. Regan

    4. Post Test: The Nuts and Bolts of Hematopoietic Cell Transplantation (HCT)

    1. Autologous HCT: A Deeper Dive - Dr. R. Gregory Bociek

    2. Post Test - Autologous HCT: A Deeper Dive

    1. Allogeneic HCT: A Deeper Dive Dr. Minoo Battiwalla

    2. Post Test - Allogeneic HCT: A Deeper Dive

    1. Unique Psychosocial Challenges for Autologous and Allogeneic HCT Patients and Care Partners - Dr. Elizabeth M. Muenks

    2. Post Test - Unique Psychosocial Challenges for Autologous and Allogeneic HCT Patients and Care Partners

    1. 5a - Graft-versus-Host-Disease - It Takes a Village - Medical Issues - Dr. Amin M. Alousi

    2. 5b - Living with Graft-versus-Host Disease: The Patient & Caregiver Experience – Psychosocial Issues - Dr. Michelle Bishop

    3. Post Test - Graft-versus-Host Disease (GVHD): Trading an Acute Disease for a Chronic Disease

About this course

  • $199.00
  • 7 hours of video content

Take the Course Now

Approved CE Provider

PSYCHOLOGISTS
Empathie, LLC is approved by the American Psychological Association to sponsor continuing education for psychologists. Empathie, LLC maintains responsibility for this program and its content.
COUNSELORS. Find Empathy has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7257. Programs that do not qualify for NBCC credit are clearly identified. Find Empathy is solely responsible for all aspects of the programs.
SOCIAL WORKERS
Find Empathy, #1817, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers.  State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Find Empathy maintains responsibility for this course.  ACE provider approval period: 5/14/2023-5/14/2026.   Social workers completing this course receive 7 continuing education credits.
                                                 
Stem Cell Transplant and CAR T-cell Therapy: The Patient and Care Partner Experience, Course #5321, is approved by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program to be offered by Find Empathy as an individual  Regulatory boards are the final authority on courses accepted for continuing education credit. ACE course approval period: 11/06/2023 - 11/06/2025. Social workers completing this course receive 7 clinical continuing education credits. 



How to Take this Course & Criteria to Receive CE Credit

  • ENROLL in this course

  • COMPLETE COURSE CONTENT by finishing all modules.

  • TAKE THE POST-TEST assessment and achieve a passing grade of at least 75%

  • Complete the COURSE EVALUATION

Remember, full attendance is required for all CE activities. This means you will be asked to certify that you watched all the videos included in this course.

Once you have completed the above steps, your course certificate will automatically populate for download. It can be downloaded immediately, emailed, and will be available for future download.

Accommodations

It is absolutely critical that our program exemplifies accessibility for all participants.

We seek to ensure all participants are able to fully, equally, and independently access the educational content. Our goal is to have a website that is perceivable, operable, understandable, and robust. If you have any difficulty navigating the website, we want to know! Please contact us at [email protected].

CE credits require a post-test assessment. The assessment is untimed and provided in writing on the course website. However, for individuals with visual impairments, or those that may benefit from an orally presented post-test and program evaluation, contact us. We will work with you to find an alternative option for completing the course post-test and program evaluation.

We remain available and open to ANY additional requests for format modification or additional assistance.

If any accommodations are needed to enroll or participate in the course, or complete the post-test and course evaluation, please contact us at [email protected].

Access & Expiration Information

COURSE ACCESS
Once enrolling in a course, you will have 30 days to complete the post-test and course evaluation. If your access lapses before completing all tasks, you may need to re-enroll.

CERTIFICATE ACCESS
Once you have completed the post-test and program evaluation, your certificate will be immediately available for download. Find Empathy will keep course certificates on file for 7 years. If a certificate is needed log into your Find Empathy account and download it, or contact: [email protected].

POST TEST RETAKE POLICY
You are allotted 3 retries to achieve the acceptable 75% passing grade.

Additional Information

WHO IS THE COURSE FOR?
This course is intended for psychologists, social workers, mental health counselors, and therapists. The instructional level is intermediate. We assume that participants already have psycho-oncology educational background and experience.

COURSE FORMAT
The primary format is a non-interactive distance-learning continuing education course presented through a series of videos.

COMMERCIAL SUPPORT
There was no commercial support provided for this CE program, the content, or to the instructor(s).

QUESTIONS?
Contact us at [email protected]. We will do our best to return your email within 24-48 hours during business hours: Monday through Friday, 9am to 5pm eastern.

If you have any questions, concerns, or grievances please email us at [email protected].

You can also see our grievance policy via the following link: https://findempathy.com/grievance